Sleep Disorder Connect
  • Saved
Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study

Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study

Source : https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00085-0/fulltext

Subcutaneous night-time only apomorphine infusion improved sleep disturbances according to difference on PDSS score, with an overall safety profile consistent with previous studies in Parkinson's disease. This treatment might be...


Interpretation: Subcutaneous night-time only apomorphine infusion improved sleep disturbances according to difference on PDSS score, with an overall safety profile consistent with previous studies in Parkinson's disease. This treatment might be useful to manage sleep disturbances in patients with advanced Parkinson's disease and moderate to...

  • Saved
Common Sleep Disorders in Adults: Diagnosis and Management - PubMed

Common Sleep Disorders in Adults: Diagnosis and Management - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35426627/

Sleep disorders are common in the general adult population and are associated with adverse effects such as motor vehicle collisions, decreased quality of life, and increased mortality. Patients with sleep...



Relevance: Sleep disorders are common in the general adult population and are associated with adverse effects such as motor vehicle collisions, decreased quality of life, and increased mortality. Patients with sleep disorders can be categorized into three groups: people with problems falling asleep, people with behavior and movement...

  • Saved
Cognitive behavioral therapy for insomnia helps to reverse cognitive impairment in insomnia patients - PubMed

Cognitive behavioral therapy for insomnia helps to reverse cognitive impairment in insomnia patients - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35371411/

1 Universidad Nacional Autónoma de México, Programa de Maestría y Doctorado en Psicología - Coyoacan - Mexico. 2 Universidad Autónoma Metropolitana, Sleep Disorders Clinic - Iztapalapa - Mexico. 3 Universidad...


Discussion: CBT-I is not only an effective tool for the treatment of insomnia but also helps to ameliorate cognitive performance.

  • 4yr
    Key Points • Source: Sleep Science • Conclusion/Relevance: “CBT-I is not only an effective tool for the treatment of insomnia but also helps to ameliorate cognitive performance.” • In the current study, Mexican researchers recruited volunteers Show More
  • Saved
Clinical characterization of insomnia in adolescents - an integrated approach to psychopathology - PubMed

Clinical characterization of insomnia in adolescents - an integrated approach to psychopathology - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35398628/

doi: 10.1016/j.sleep.2022.03.010. Online ahead of print. 1 Center for Health Sciences, SRI International, Menlo Park, CA, USA. 2 Center for Health Sciences, SRI International, Menlo Park, CA, USA; Brain Function...


Conclusions: Findings highlight clinical and sex-specific characteristics of adolescent insomnia, with network analyses revealing a complex interplay between clinical, behavioral, and psychosocial domains. Adolescents with insomnia symptoms, particularly girls, may benefit from interventions to improve negative cognition, mood, and stress, and...

  • Saved
Excessive daytime sleepiness associated with narcolepsy | NSS

Excessive daytime sleepiness associated with narcolepsy | NSS

Source : https://www.dovepress.com/calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-a-lower--peer-reviewed-fulltext-article-NSS

Lower-sodium oxybate (Xywav™) is a medication for people with narcolepsy 7 years of age and older. Xywav treats excessive daytime sleepiness (EDS) and cataplexy (attacks of muscle weakness triggered by...


Conclusion: This review summarizes the background on oxybate as a therapeutic agent and its potential mechanism of action on the gamma-aminobutyric acid type B (GABAB) receptor at noradrenergic and dopaminergic neurons, as well as at thalamocortical neurons. The rationale leading to the development of LXB as a lower-sodium alternative to SXB and...